Which is better, EGFR-TKI mono or combination for non-small cell lung cancer with mutated EGFR?

被引:2
作者
Tanzawa, Shigeru [1 ]
Ishihara, Masashi [1 ]
Haruyama, Terunobu [1 ]
Ochiai, Ryosuke [1 ]
Sakamoto, Takahiko [1 ]
Honda, Takeshi [1 ]
Ota, Shuji [1 ]
Ichikawa, Yasuko [1 ]
Watanabe, Kiyotaka [1 ]
Seki, Nobuhiko [1 ]
机构
[1] Teikyo Univ, Sch Med, Dept Internal Med, Div Med Oncol, Tokyo, Japan
关键词
BRAIN METASTASES; XENOGRAFT MODELS; GROWTH-FACTOR; OSIMERTINIB; BEVACIZUMAB;
D O I
10.21037/tcr.2019.08.18
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:2223 / 2229
页数:7
相关论文
共 25 条
[1]  
[Anonymous], 2019, J CLIN ONCOL S
[2]   Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma [J].
Cascone, Tina ;
Herynk, Matthew H. ;
Xu, Li ;
Du, Zhiqiang ;
Kadara, Humam ;
Nilsson, Monique B. ;
Oborn, Carol J. ;
Park, Yun-Yong ;
Erez, Baruch ;
Jacoby, Joerg J. ;
Lee, Ju-Seog ;
Lin, Heather Y. ;
Ciardiello, Fortunato ;
Herbst, Roy S. ;
Langley, Robert R. ;
Heymach, John V. .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (04) :1313-1328
[3]   Cetuximab Response of Lung Cancer-Derived EGF Receptor Mutants Is Associated with Asymmetric Dimerization [J].
Cho, Jeonghee ;
Chen, Liang ;
Sangji, Naveen ;
Okabe, Takafumi ;
Yonesaka, Kimio ;
Francis, Joshua M. ;
Flavin, Richard J. ;
Johnson, William ;
Kwon, Jihyun ;
Yu, Soyoung ;
Greulich, Heidi ;
Johnson, Bruce E. ;
Eck, Michael J. ;
Jaenne, Pasi A. ;
Wong, Kwok-Kin ;
Meyerson, Matthew .
CANCER RESEARCH, 2013, 73 (22) :6770-6779
[4]   Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification [J].
Furugaki, Koh ;
Fukumura, Junko ;
Iwai, Toshiki ;
Yorozu, Keigo ;
Kurasawa, Mitsue ;
Yanagisawa, Mieko ;
Moriya, Yoichiro ;
Yamamoto, Kaname ;
Suda, Kenichi ;
Mizuuchi, Hiroshi ;
Mitsudomi, Tetsuya ;
Harada, Naoki .
INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (04) :1024-1032
[5]   Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma [J].
Ilhan-Mutlu, Ayseguel ;
Osswald, Matthias ;
Liao, Yunxiang ;
Goemmel, Miriam ;
Reck, Martin ;
Miles, David ;
Mariani, Paola ;
Gianni, Luca ;
Lutiger, Beatrix ;
Nendel, Viktor ;
Srock, Stefanie ;
Perez-Moreno, Pablo ;
Thorsen, Frits ;
von Baumgarten, Louisa ;
Preusser, Matthias ;
Wick, Wolfgang ;
Winkler, Frank .
MOLECULAR CANCER THERAPEUTICS, 2016, 15 (04) :702-710
[6]   Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations [J].
Iuchi, Toshihiko ;
Shingyoji, Masato ;
Itakura, Meiji ;
Yokoi, Sana ;
Moriya, Yasumitsu ;
Tamura, Hajime ;
Yoshida, Yasushi ;
Ashinuma, Hironori ;
Kawasaki, Koichiro ;
Hasegawa, Yuzo ;
Sakaida, Tsukasa ;
Iizasa, Toshihiko .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) :674-679
[7]   Real-time imaging reveals the single steps of brain metastasis formation [J].
Kienast, Yvonne ;
von Baumgarten, Louisa ;
Fuhrmann, Martin ;
Klinkert, Wolfgang E. F. ;
Goldbrunner, Roland ;
Herms, Jochen ;
Winkler, Frank .
NATURE MEDICINE, 2010, 16 (01) :116-U157
[8]   CNS Anticancer Drug Discovery and Development Conference White Paper [J].
Levin, Victor A. ;
Tonge, Peter J. ;
Gallo, James M. ;
Birtwistle, Marc R. ;
Dar, Arvin C. ;
Iavarone, Antonio ;
Paddison, Patrick J. ;
Heffron, Timothy P. ;
Elmquist, William F. ;
Lachowicz, Jean E. ;
Johnson, Ted W. ;
White, Forest M. ;
Sul, Joohee ;
Smith, Quentin R. ;
Shen, Wang ;
Sarkaria, Jann N. ;
Samala, Ramakrishna ;
Wen, Patrick Y. ;
Berry, Donald A. ;
Petter, Russell C. .
NEURO-ONCOLOGY, 2015, 17 :1-26
[9]   Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer [J].
Mok, T. S. ;
Wu, Y. -L. ;
Ahn, M. -J. ;
Garassino, M. C. ;
Kim, H. R. ;
Ramalingam, S. S. ;
Shepherd, F. A. ;
He, Y. ;
Akamatsu, H. ;
Theelen, W. S. M. E. ;
Lee, C. K. ;
Sebastian, M. ;
Templeton, A. ;
Mann, H. ;
Marotti, M. ;
Ghiorghiu, S. ;
Papadimitrakopoulou, V. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (07) :629-640
[10]  
Nakagawa K, 2019, J CLIN ONCOL, V37